La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Mitsui Bilan de santé

Santé financière contrôle des critères 4/6

Mitsui possède un total de capitaux propres de ¥8,156.8B et une dette totale de ¥5,013.7B, ce qui porte son ratio d'endettement à 61.5%. Son actif total et son passif total sont ¥17,979.9B et de ¥9,823.1B. L'EBIT de Mitsui est ¥551.1B ce qui fait que son ratio de couverture des intérêts -5.4. Elle dispose de liquidités et de placements à court terme de ¥1,035.6B.

Informations clés

61.5%

Ratio d'endettement

JP¥5.01t

Dette

Ratio de couverture des intérêts	-5.4x
Argent liquide	JP¥1.04t
Fonds propres	JP¥8.16t
Total du passif	JP¥9.82t
Total des actifs	JP¥17.98t

Mises à jour récentes de la santé financière

Mitsui (TSE:8031) Takes On Some Risk With Its Use Of Debt

May 25

Recent updates

Revenue Beat: Mitsui & Co., Ltd. Beat Analyst Estimates By 12%

Aug 03

Mitsui & Co., Ltd.'s (TSE:8031) Earnings Are Not Doing Enough For Some Investors

Jul 15

Mitsui (TSE:8031) Takes On Some Risk With Its Use Of Debt

May 25

Mitsui & Co., Ltd. Just Beat EPS By 8.6%: Here's What Analysts Think Will Happen Next

May 04

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 8031 ( ¥6,320.5B ) dépassent ses passifs à court terme ( ¥4,448.5B ).

Passif à long terme: Les actifs à court terme de 8031 ( ¥6,320.5B ) dépassent ses passifs à long terme ( ¥5,374.6B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 8031 ( 48.8% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de 8031 a été réduit de 110.1% à 61.5% au cours des 5 dernières années.

Couverture de la dette: La dette de 8031 n'est pas bien couverte par le flux de trésorerie opérationnel ( 15.6% ).

Couverture des intérêts: 8031 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

Mitsui Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

Mitsui (TSE:8031) Takes On Some Risk With Its Use Of Debt

Recent updates

New minor risk - Share price stability

Now 31% undervalued after recent price drop

Revenue Beat: Mitsui & Co., Ltd. Beat Analyst Estimates By 12%

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Mitsui & Co., Ltd.'s (TSE:8031) Earnings Are Not Doing Enough For Some Investors

BP, Shell and Total Take Stake in UAE Energy Project

Final dividend of JP¥50.00 announced

High number of new directors

Mitsui & Co., Ltd. to Report Q1, 2025 Results on Aug 01, 2024

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Mitsui (TSE:8031) Takes On Some Risk With Its Use Of Debt

Mitsui & Co., Ltd. Just Beat EPS By 8.6%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 7.8% to JP¥7,378

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 40,000,000 shares, representing 2.66% for ¥200,000 million.

Rohto Pharmaceutical Co.,Ltd. (TSE:4527), Mitsui & Co., Ltd. (TSE:8031) and others agreed to acquire an 86% stake in Eu Yan Sang International Ltd from Blanca Investments Pte. Ltd., Tower Capital Asia and founding family for approximately SGD 690 million.

Mitsui (TSE:8031) Is Due To Pay A Dividend Of ¥85.00

Mitsui & Co., Ltd. to Report Fiscal Year 2024 Results on May 01, 2024

Upcoming dividend of JP¥85.00 per share

Mitsui & Co., Ltd.'s (TSE:8031) Prospects Need A Boost To Lift Shares

Mitsui's (TSE:8031) Dividend Will Be ¥85.00

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Third quarter 2024 earnings: Revenues exceed analyst expectations

Mitsui & Co., Ltd. Announces Change of Director

Mitsui & Co., Ltd., Annual General Meeting, Jun 19, 2024

Mitsui & Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

RGF Staffing B.V. entered into share sale and purchase agreement to acquire additional 30% stake in RGF Staffing Delaware, Inc. from Mitsui & Co., Ltd. (TSE:8031) for approximately 130 million.

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 12,500,000 shares, representing 0.83% for ¥50,000 million.

Second quarter 2024 earnings: EPS misses analyst expectations

BEMAC Corporation and Mitsui & Co., Ltd. entered into a share purchase agreement to acquire 100% of the shares of The Switch Engineering Oy from YASKAWA Electric Corporation.

Mitsui & Co., Ltd. to Report First Half, 2024 Results on Oct 31, 2023

Upcoming dividend of JP¥75.00 per share at 2.6% yield

Mitsui & Co., Ltd. (TSE:8031) completed the acquisition of 49% stake in Solar Park Kassø Aps from European Energy A/S.

Mitsui & Co., Ltd. (TSE:8031) acquired 33.3% stake in Terreva Renewables, LLC from CIM Group, L.P.

CPC Reportedly Set for Dorado Stake

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Dermaceutical Laboratories Limited Liability Company.

Mitsui & Co., Ltd. to Report Q1, 2024 Final Results on Aug 09, 2023

Beacon Rail Metro Finance B.V. signed a share purchase agreement to acquire Mitsui Rail Capital Europe B.V. from Mitsui & Co., Ltd. (TSE:8031).

Yangzijiang Shipbuilding (Holdings) Ltd. (SGX:BS6) acquired additional 5% stake in Jiangsu Yangzi-Mitsui Shipbuilding Co. Ltd. from Mitsui & Co., Ltd. (TSE:8031) and Mitsui E&S Shipbuilding Co., Ltd for CNY 43.2 million.

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Mitsui & Co., Ltd. (TSE:8031) executed a share purchase agreement to acquire STATS (UK) Ltd from BGF Investment Management Ltd. and others.

Mitsui & Co., Ltd. to Report Q1, 2024 Results on Aug 01, 2023

Mitsui & Co., Ltd. (TSE:8031) entered into binding agreements to acquire minority shareholder in EURICOM S.p.a. for enterprise value approximately €500 million.

Mitsui, Osaka Gas Reportedly Bid for ReNew Energy's Commercial and Industrial Project Portfolio

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of JP¥70.00 per share at 3.4% yield

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire remaining 50% stake in Aim Services Co., Ltd. from Aramark (NYSE:ARMK) for ¥70 billion.

Mitsui & Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2023

Mitsui & Co., Ltd. Announces Management Changes

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Sumitomo Pharma Animal Health Co., Ltd. from Sumitomo Pharma Co., Ltd. (TSE:4506).

Mitsui & Co., Ltd. to Report Nine Months, 2023 Results on Feb 03, 2023

Price target increased to JP¥4,418

CFW Partners, L.P, Mitsui & Co., Ltd. (TSE:8031), Fuyo General Lease Co., Ltd. (TSE:8424) and JA Mitsui Leasing, Ltd. submitted a non-binding proposal to acquire remaining 2.1% stake in Willis Lease Finance Corporation (NasdaqGM:WLFC) for $29.3 million.

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

ACTIS GP LLP completed the acquisition of 40% share in MT Falcon Holdings Company S.A.P.I. de C.V. from Mitsui & Co., Ltd.

Woodside Reportedly Weighs Up Options for Scarborough

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines